SCHEMBL21189202

SCHEMBL21189202

COC(=O)N[C@H]1CCOc2c(C(=O)Nc3ccc(F)c(F)c3)cc([N+](=O)[O-])cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.37
MEN1 O00255 6/20 0.37
KMT2A Q03164 6/20 0.37
NPC1 O15118 4/20 0.37
HSP90AA1 P07900 1/20 0.37
PKM P14618 1/20 0.37
PAX8 Q06710 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
RAB9A P51151 6/20 0.37
MAPK1 P28482 2/20 0.37
MAOB P27338 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
ALOX5 P09917 2/20 0.36
PPARG P37231 2/20 0.36
HTT P42858 3/20 0.35
LMNA P02545 2/20 0.35
CASP3 P42574 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19973529 0.90 MAPT (0.39) MAPTMEN1KMT2ANPC1PAX8
SCHEMBL19973532 0.90 MAPT (0.39) MAPTMEN1KMT2ANPC1PAX8
SCHEMBL19973504 0.90 RAB9A (0.37) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL19973508 0.90 RAB9A (0.37) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL21189358 0.85 MAOB (0.39) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL19973895 0.84 MAPT (0.35) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL19973894 0.84 MAPT (0.35) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL19973897 0.84 MAPT (0.35) MAPTMEN1KMT2ANPC1RAB9A
SCHEMBL21189206 0.83 TP53 (0.42) MAPTNPC1RAB9AMAOBSMN1; SMN2
SCHEMBL21189262 0.83 TP53 (0.42) MAPTNPC1RAB9AMAOBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME CBX8, HAVCR2, HCCS MAPT 3165/4885MEN1 1933/4885KMT2A 155/4885
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same CBX8, HAVCR2, HCCS MAPT 3165/4885MEN1 1933/4885KMT2A 155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.